Professional
Added to YB: 2024-05-08
Pitch date: 2024-03-31
CDNA [bullish]
CareDx, Inc
+93.96%
current return
Author Info
No bio for this author
Company Info
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
Market Cap
$819.6M
Pitch Price
$10.60
Price Target
21.18 (+3%)
Dividend
N/A
EV/EBITDA
-88.86
P/E
13.12
EV/Sales
1.82
Sector
Biotechnology
Category
turnaround
Baron Discovery Fund Portfolio Holding: CareDx, Inc.
CDNA: Diagnostic co facilitating organ donor matches & rejection monitoring. Despite major CMS reimbursement cut, revenue growing again with expense efficiency driving cash flow breakeven by 2025. $235M cash, no debt. 1.3x EV/sales should 2x+. Potential CMS reversal is blue sky scenario for rapid multi-bagger.
Read full article (1 min)